ArticleAntimicrobial agents and chemotherapy2022

Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase-Producing Carbapenem-Resistant Pseudomonas aeruginosa.

Lina Rivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.